MAPT and Alzheimer disease: The accumulation of Amyloid‐β peptides, especially soluble oligomeric species, has been implicated in triggering downstream pathogenic processes including tau pathology and neuronal loss in AD (Long & Holtzman, 2019) while Drosha activity appears to be required for cell survival under stress conditions (Yang et al., 2015).